Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Jorge Riera Knorrenschild"'
Autor:
Sylvie Lorenzen, Alix Schwarz, Claudia Pauligk, Eray Goekkurt, Gertraud Stocker, Jorge Riera Knorrenschild, Gerald Illerhaus, Tobias Dechow, Markus Moehler, Jean-Charles Moulin, Daniel Pink, Michael Stahl, Marina Schaaf, Thorsten Oliver Goetze, Salah-Eddin Al-Batran
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Paclitaxel in combination with ramucirumab is the standard of care second-line therapy in gastro-esophageal adenocarcinoma (GEA). As the number of taxane pretreated patients in the perioperative or first-line setting is increasing
Externí odkaz:
https://doaj.org/article/fc19cbb7961b4d8e905efac4a9da10d4
Autor:
Carola Seifart, Martin Koch, Nico Leppin, Katharina Nagelschmidt, Jorge Riera Knorrenschild, Nina Timmesfeld, Winfried Rief, Pia von Blanckenburg
Publikováno v:
BMC Palliative Care, Vol 19, Iss 1, Pp 1-10 (2020)
Abstract Background To assure patient-centred end-of-life care, palliative interventions need to account for patients’ preferences. Advance care planning (ACP) is a structured approach that allows patients, relatives and physicians to discuss end-o
Externí odkaz:
https://doaj.org/article/24ad1e9d2191462aa0fad86252a457fd
Autor:
Joseph Tintelnot, Eray Goekkurt, Mascha Binder, Peter Thuss-Patience, Sylvie Lorenzen, Jorge Riera Knorrenschild, Albrecht Kretzschmar, Thomas Ettrich, Udo Lindig, Lutz Jacobasch, Daniel Pink, Salah-Eddin Al-Batran, Axel Hinke, Susanna Hegewisch-Becker, Sven Nilsson, Carsten Bokemeyer, Alexander Stein
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Esophagogastric adenocarcinoma (EGA) currently represents a main cause of cancer related death. Despite an intensified treatment for locally advanced or metastatic EGA with a doublet chemotherapy consisting of a platinum compound
Externí odkaz:
https://doaj.org/article/8acdade897524e90ab934f07ed739b00
Autor:
Martin Fehr, Hanne Hawle, Stefanie Hayoz, Peter Thuss-Patience, Sabina Schacher, Jorge Riera Knorrenschild, Donat Dürr, Wolfram T. Knoefel, Holger Rumpold, Michael Bitzer, Martin Zweifel, Panagiotis Samaras, Ulrich Mey, Marc Küng, Ralph Winterhalder, Wolfgang Eisterer, Viviane Hess, Marie-Aline Gérard, Arnoud Templeton, Michael Stahl, Thomas Ruhstaller, for the Swiss Group for Clinical Cancer Research (SAKK), the German Esophageal Cancer Study Group, the Austrian Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT), the Fédération Francophone de Cancérologie Digestive (FFCD) / Fédération de Recherche en Chirurgie (FRENCH)
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background High rates of venous thromboembolic events (VTEs), mainly in advanced disease, are reported for patients with cancer of the upper gastrointestinal tract (stomach, pancreas) and for treatment with cisplatin. Methods Exploratory ana
Externí odkaz:
https://doaj.org/article/0081a584ac4248f78e6831be4adafd73
Autor:
Salah-Eddin Al-Batran, Thorsten O. Goetze, Daniel W. Mueller, Arndt Vogel, Michael Winkler, Sylvie Lorenzen, Alexander Novotny, Claudia Pauligk, Nils Homann, Thomas Jungbluth, Christoph Reissfelder, Karel Caca, Steffen Retter, Eva Horndasch, Julia Gumpp, Claus Bolling, Karl-Hermann Fuchs, Wolfgang Blau, Winfried Padberg, Michael Pohl, Andreas Wunsch, Patrick Michl, Frank Mannes, Matthias Schwarzbach, Harald Schmalenberg, Michael Hohaus, Christian Scholz, Christoph Benckert, Jorge Riera Knorrenschild, Veit Kanngießer, Thomas Zander, Hakan Alakus, Ralf-Dieter Hofheinz, Claus Roedel, Manish A. Shah, Mitsuru Sasako, Dietmar Lorenz, Jakob Izbicki, Wolf O. Bechstein, Hauke Lang, Stefan P. Moenig
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background Historical data indicate that surgical resection may benefit select patients with metastatic gastric and gastroesophageal junction cancer. However, randomized clinical trials are lacking. The current RENAISSANCE trial addresses th
Externí odkaz:
https://doaj.org/article/5dc6e803a3084cd49c26c2fd2d3bd2f4
Autor:
Tobias Dechow, Jorge Riera‐Knorrenschild, Björn Hackanson, Jan Janssen, Holger Schulz, Ursula Oppermann, Marco Chiabudini, Ludwig Fischer von Weikersthal, Stephan Budweiser, Axel Nacke, Dagmar Taeuscher, Manfred Welslau, Karin Potthoff
Publikováno v:
International Journal of Cancer. 153:141-152
Autor:
Kerstin Hermes-Moll, Isabelle Hempler, Nicola Riccetti, Geothy Chakupurakal, Marius Fried, Jorge Riera Knorrenschild, Andreas Köhler, Franz A. Mosthaf, Henning Pelz, Stephan Schmitz, Vitali Heidt, Susanne Singer
Publikováno v:
Forum. 37:289-293
Autor:
Susanne Singer, Nicola Riccetti, Isabelle Hempler, Marius Fried, Jorge Riera Knorrenschild, Louma Kalie, Martin Merbach, Marcel Reiser, Franz Mosthaf, Vitali Heidt, Kerstin Hermes-Moll
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 149:1733-1745
Purpose We examined how migration background is associated with awareness and usage of psycho-oncology services. Methods Oncologists in community-based practices and outpatient clinics asked their patients and their relatives to complete a questionna
Autor:
Martin Sebastian, Andreas Gröschel, Sylvia Gütz, Holger Schulz, Harald Müller-Huesmann, Rüdiger Liersch, Eyck von der Heyde, Jörg Wiegand, Dieter Ukena, Joachim Bargon, Wolfgang Schütte, Jorge Riera-Knorrenschild, Jürgen R. Fischer, Frank Griesinger, Victoria Allan, Daniela Waldenberger, Christian Schumann
Publikováno v:
Journal of Immunotherapy. 45:89-99
Nivolumab was the first immune checkpoint inhibitor approved for use in advanced non-small cell lung cancer (NSCLC). This noninterventional, prospective cohort study investigates real-world effectiveness of nivolumab in pretreated NSCLC patients in G
Autor:
Anna Julia Pedrosa Carrasco, Svenja Herzog, Anna Genz, Martin Koch, Jorge Riera Knorrenschild, Teresa Machacek, Pia von Blanckenburg, Carola Seifart
Publikováno v:
Palliative Medicine. 35:1897-1907
Background: Impaired readiness may hinder purposeful advance care planning in cancer patients. To reduce barriers to participation in end-of-life decision-making, a collaborative intervention was developed combining a psycho-oncological approach of d